Reklama
twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop

UNI-EN 17:Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00

Firma: SOPHARMA AD
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Current report _ SPH EGM - 24.04.2017.doc Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 17 / 2017
Date of issue: 2017-04-20
Short name of the issuer
SOPHARMA AD
Subject
Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the “Company”) hereby notifies all shareholders of the Company, that the Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00 will take place at Sopharma Business Towers, Building B, floor 3, 5 Lachezar Stanchev Str.. The registration begins at 9:30.
All shareholders of the company are invited to participate at the General Meeting in person or by proxy.
As a prerequisite for the technical provisioning of the Extraordinary General Meeting of Shareholders, copies of all letters of attorney must be presented to the Company on paper or electronically at mdnedkova@sopharma.bg by the end of the workday preceding the date of the AGM, namely 5 p.m. on 21 April 2017.

We would like to thank all shareholders for their understanding and cooperation.
Annexes
File Description
Current report _ SPH EGM - 24.04.2017.doc
Current report _ SPH EGM - 24.04.2017.doc
Extraordinary General Meeting, convened by the Board of Directors for 24 April 2017 at 11:00

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2017-04-20 Ognian Donev Executive director

Cena akcji Sopharma

Cena akcji Sopharma w momencie publikacji komunikatu to 6.61 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.

W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.

Jesteś dziennikarzem i szukasz pracy? Napisz do nas

Masz lekkie pióro? Interesujesz się gospodarką i finansami? Możliwe, że szukamy właśnie Ciebie.

Zgłoś swoją kandydaturę

Reklama